​PHQ-9 & GAD-7 Assessment | Depression and Anxiety Screening with Automatic Scoring

​This comprehensive PHQ-9 and GAD-7 assessment combines two widely used screening and symptom-severity measures for depression and anxiety. The PHQ-9 evaluates nine depressive symptoms over the previous two weeks, while the GAD-7 evaluates seven common anxiety symptoms during the same time period. This updated version includes automatic scoring, standard severity interpretation, functional-impact questions, PHQ-9 item 9 safety follow-up, treatment-planning options, and progress tracking across repeated administrations. Results are intended to support clinical discussion and symptom monitoring and should be interpreted alongside a full clinical evaluation rather than used as stand-alone diagnostic tools.
PHQ-9 & GAD-7 Assessment | Depression and Anxiety Screening with Automatic Scoring
Depression • Anxiety • PHQ-9 • GAD-7 • Progress Tracking

PHQ-9 & GAD-7 Depression and Anxiety Assessment

This comprehensive PHQ-9 and GAD-7 assessment combines two widely used self-report screening and symptom-severity measures for depression and anxiety. The PHQ-9 evaluates nine depressive symptoms over the previous two weeks, while the GAD-7 evaluates seven common anxiety symptoms over the same period. This updated version preserves the standard scoring structure and adds functional-impact review, safety follow-up, progress tracking, treatment-planning options, Save/Restore, printable results, and a downloadable clinical summary.

Mark Zauss, BC-TMC, LMHC, LPC, CCMHC, NCC, ASDCS, CCTP, CCTP II, NATC, ADHD-CCSP, C-DBT, C-PD
Double Board Certified Counseling Services, Inc.
About These Measures

PHQ-9 and GAD-7

The existing page uses the standard 0–3 response scale for both measures: 0 = Not at all, 1 = Several days, 2 = More than half the days, and 3 = Nearly every day. The PHQ-9 total ranges from 0–27 and the GAD-7 total ranges from 0–21. citeturn727185view0turn775790search1turn727185search0

Screening, not diagnosis: These measures are useful for identifying symptom burden and monitoring change over time. Scores should be interpreted alongside clinical interview, functional impairment, medical factors, medication effects, trauma history, substance use, and differential diagnosis.
Client Information

Assessment Context

PHQ-9

Depression Symptoms — Last 2 Weeks

1Little interest or pleasure in doing things
2Feeling down, depressed, or hopeless
3Trouble falling or staying asleep, or sleeping too much
4Feeling tired or having little energy
5Poor appetite or overeating
6Feeling bad about yourself — or that you are a failure or have let yourself or your family down
7Trouble concentrating on things, such as reading the newspaper or watching television
8Moving or speaking so slowly that other people could have noticed — or the opposite, being so fidgety or restless that you have been moving around a lot more than usual
9Thoughts that you would be better off dead or of hurting yourself in some way
Safety note: Any response above “Not at all” to PHQ-9 item 9 warrants direct clinical follow-up. The PHQ-9 does not replace a suicide-risk assessment. If there is imminent risk, intent, a plan, or inability to remain safe, use emergency/crisis resources immediately.
GAD-7

Anxiety Symptoms — Last 2 Weeks

1Feeling nervous, anxious, or on edge
2Not being able to stop or control worrying
3Worrying too much about different things
4Trouble relaxing
5Being so restless that it is hard to sit still
6Becoming easily annoyed or irritable
7Feeling afraid as if something awful might happen
Functional Impact

Current Daily Functioning

Safety Follow-Up

Additional Safety & Clinical Review

Treatment Planning

Possible Areas for Follow-Up

Progress Tracking

Compare With a Prior Assessment

Results

PHQ-9 & GAD-7 Scoring Summary

PHQ-9 total0 / 27--
GAD-7 total0 / 21--
PHQ-9 item 9--Safety follow-up if >0
Combined symptom load0 / 48Descriptive only; not a validated combined scale
PHQ-9 change--Compared with prior score
GAD-7 change--Compared with prior score
Severity Guides

Standard Descriptive Ranges

PHQ-9Severity
0–4Minimal
5–9Mild
10–14Moderate
15–19Moderately severe
20–27Severe
GAD-7Severity
0–4Minimal
5–9Mild
10–14Moderate
15–21Severe

The original PHQ-9 validation identified cut points of 5, 10, 15, and 20 for increasing depression severity. The GAD-7 commonly uses 5, 10, and 15 as mild, moderate, and severe anxiety thresholds. citeturn775790search1turn727185search2

AI-Style Summary

Automated Clinical Summary

This narrative is generated locally using rule-based logic. No information is sent to an external AI service. Review and edit before including it in clinical documentation.
Complete the assessments and select “Calculate + AI-Style Summary.”
Clinical Sources & References

Selected Sources

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613. The PHQ-9 scores nine depression symptoms from 0–3 for a total range of 0–27 and includes a functional-difficulty item.

Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. The GAD-7 is a seven-item self-report measure with a total score from 0–21.

Mark Zauss Therapy. Existing PHQ-9 & GAD-7 page. The live page currently includes both measures, functional-difficulty questions, automatic totals, severity bands, item-9 display, response counts, CSV download, print, and reset.

The additional functional-impact ratings, safety checklist, treatment-planning section, prior-score comparison, combined symptom-load display, and AI-style summary are clinician-created additions and are not part of the original PHQ-9 or GAD-7 scoring instruments.